Friday, March 03, 2023

COVID-19 Vaccines Remain Pregnancy Category X: Products Should Never Have Been Administered in Pregnant Women and Those of Childbearing Age

 

All drugs have a pregnancy category designation giving mothers and doctors guidance on what is known and how safe products are during pregnancy. 

Category A: The possibility of fetal harm appears remote. Extremely few drugs exist in this category (e.g., multiple vitamins).

  • Category B: If there is a clinical need for a drug in this category, they are considered safe to use. Examples: acetaminophen, amoxicillin.

  • Category C: These drugs should be given only if the potential benefit justifies the potential risk to the fetus. Examples: fluoroquinolones, gentamicin, saccharin, aspirin.

  • Category D: There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk. They should only be used in pregnancy when the alternatives are worse. Examples: tetracyclines, ACE inhibitors, and most antineoplastics.

  • Category X: The risk of use of the drug in pregnant women clearly outweighs any possible benefit. The drug is contraindicated in women who are or may become pregnant. Examples: thalidomide, oral contraceptives, statins, all COVID-19 vaccines.

I published an article in 2021 with Dr. Raphael Stricker, who advises one of the largest fetal loss centers in the country, warning women that the COVID-19 vaccine should be considered pregnancy category X. This designation should have been assigned by the vaccine manufacturers and agreed to by the FDA and properly placed on all vaccine program documents since pregnancy and childbearing age without contraception were exclusions from the EUA registration trials. 

Shockingly, in the very first week of mass vaccination in December of 2020, news reels depicted well-intentioned pregnant mothers getting injected with synthetic lipid nanoparticles laced with long-lasting mRNA coding for the Wuhan Institute of Virology Spike protein. How could this be happening with no mutagenicity or teratogenicity studies? How could good clinical practice by doctors be abandoned?

GO READ THE WHOLE THING


No comments: